Centiloid cut-off values for optimal agreement between PET and CSF core AD biomarkers
Juan Domingo Gispert(Lund University), Javier Pavı́a(Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine), Kaj Blennow(Sahlgrenska University Hospital), Carles Falcón, Anna Brugulat‐Serrat(Pasqual Maragall Foundation), José Luís Molinuevo(Pasqual Maragall Foundation), Andrés Perissinotti(Hospital Clínic de Barcelona), Aida Niñerola‐Baizán(Hospital Clínic de Barcelona), Gemma Salvadó(Lund University), Oriol Grau‐Rivera(Pasqual Maragall Foundation), Henrik Zetterberg(University of Wisconsin–Madison), Marc Suárez‐Calvet(Pasqual Maragall Foundation), Carolina Minguillón(Pasqual Maragall Foundation), Karine Fauria(Pasqual Maragall Foundation), Francisco Lomeña(Hospital Clínic de Barcelona)
Cited by 201
Related Papers
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease
|Alzheimer s & Dementia|2014|3.1k
Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup
|Alzheimer s & Dementia|2024|2.3k
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
|New England Journal of Medicine|2014|2k